Literature DB >> 8466107

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months.

D A Mitchison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8466107     DOI： 10.1164/ajrccm/147.4.1062

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  72 in total

Review 1.  The challenge of new drug discovery for tuberculosis.

Authors:  Anil Koul; Eric Arnoult; Nacer Lounis; Jerome Guillemont; Koen Andries
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

2.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

3.  Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.

Authors:  Marc Weiner; Thomas J Prihoda; William Burman; John L Johnson; Stefan Goldberg; Nesri Padayatchi; Paula Duran; Melissa Engle; Grace Muzanye; Roy D Mugerwa; A Willem Sturm
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

4.  Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.

Authors:  Moises Palaci; Reynaldo Dietze; David Jamil Hadad; Fabiola Karla Corrêa Ribeiro; Renata Lyrio Peres; Solange Alves Vinhas; Ethel Leonor Noia Maciel; Valdério do Valle Dettoni; Libby Horter; W Henry Boom; John L Johnson; Kathleen D Eisenach
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

Review 5.  Current prospects for the fluoroquinolones as first-line tuberculosis therapy.

Authors:  Howard Takiff; Elba Guerrero
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

6.  Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis.

Authors:  M T Barakat; J Scott; J M Hughes; M Walport; J Calam; J S Friedland; P W Ind; C McKenna
Journal:  BMJ       Date:  1996-12-14

7.  Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome.

Authors:  Teresa López; Milagros Moreno; Fernando Salvador; Adriano Zacarías; Rosa de Carvalho; Estevao Tomás; Gabriel Estevao; Arlette Nindia Eugenio; Joaquin Burgos; Elena Sulleiro; Israel Molina; Vicenç Falcó
Journal:  Pathog Glob Health       Date:  2013-01       Impact factor: 2.894

8.  CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Authors:  Payam Nahid; Jussi Saukkonen; William R Mac Kenzie; John L Johnson; Patrick P J Phillips; Janet Andersen; Erin Bliven-Sizemore; John T Belisle; W Henry Boom; Annie Luetkemeyer; Thomas B Campbell; Kathleen D Eisenach; Richard Hafner; Jeffrey L Lennox; Mamodikoe Makhene; Susan Swindells; M Elsa Villarino; Marc Weiner; Constance Benson; William Burman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

9.  13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

Authors:  Mandeep S Jassal; Gueno G Nedeltchev; Jong-Hee Lee; Seong Won Choi; Viorel Atudorei; Zachary D Sharp; Vojo Deretic; Graham S Timmins; William R Bishai
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

10.  Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.

Authors:  William R Mac Kenzie; Charles M Heilig; Lorna Bozeman; John L Johnson; Grace Muzanye; Denise Dunbar; Kenneth C Jost; Lois Diem; Beverly Metchock; Kathleen Eisenach; Susan Dorman; Stefan Goldberg
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.